Uniquity One (uni)
Clinical trials sponsored by Uniquity One (uni), explained in plain language.
-
New asthma drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug, solrikitug, in 145 adults with asthma who already use daily inhalers. The goal is to see if the drug can safely lower certain immune cells (eosinophils) in the blood and improve asthma control compared to a placebo. It is a Phase 2 trial, me…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug shows promise for swallowing disorder
Disease control OngoingThis study tests an experimental drug called NSI-8226 (solrikitug) in adults with eosinophilic esophagitis, a condition that causes trouble swallowing due to inflamed esophagus. About 184 participants will receive either the drug or a placebo to see if it reduces inflammation and…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC